Digital fetal scalp stimulation during labor to identify fetal hypoxia
Official title: Evaluation of Fetal Response to Intrapartum Digital Fetal Scalp Stimulation Upon Detection of Suspected Loss of Fetal Well-being in Suspicious and Pathologic Cardiotocographic Recordings, to Identify Intrapartum Fetal Hypoxia.
Run by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · NCT07035028 · Data updated 2026-11-12
This trial will see if a brief digital stimulation of the fetal scalp during labor can improve heart-rate tracings and scalp blood results for babies with suspicious or pathological cardiotocography.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 182 (estimated) |
| Sponsor | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Academic / other |
| Locations | 2 sites (Madrid and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT07035028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Term (≥37 weeks), singleton, cephalic pregnancies with suspicious or pathological CTG patterns and eligibility for scalp evaluation are the intended participants.
✕Probably not a fit
This approach will not be appropriate for patients under 18, those with contraindications to scalp procedures, maternal HIV/hepatitis, or fetuses at increased risk of hemorrhage.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
When cardiotocography (CTG) shows a suspicious or pathological fetal heart-rate pattern during labor, clinicians perform a brief digital fetal scalp stimulation (dFSS) during a vaginal exam and record the immediate CTG response. Investigators compare those CTG responses with the reference fetal scalp blood (FBS) result, which measures fetal blood gases and pH. The dFSS intervention is short and non-invasive and is tested alongside standard care, with FBS performed as the gold-standard comparator when indicated. The study enrolls term, singleton, cephalic pregnancies at participating Madrid hospitals and tracks whether dFSS leads to improved CTG patterns and normal FBS values.
Why it matters
Potential benefit: If successful, dFSS could reduce the need for invasive fetal scalp blood sampling and speed decision-making about interventions during labor.
How similar studies have gone: Previous smaller studies and clinical reports have shown that scalp stimulation can produce fetal heart-rate accelerations, but large direct comparisons with fetal scalp blood sampling are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: Women with singleton pregnancy. Cephalic presentation. Gestational age greater than or equal to 37 weeks. Pathological cardiotocographic record according to the criteria published by FIGO and with indication to perform a second-line complementary test, in our case a gold standard test of fetal scalp blood FBS, which confirms or not if there is a risk of loss of fetal well-being and the need for fetal extraction. Signature of HIP and CI for data collection. Exclusion criteria: Under 18 years of age. Contraindication for FBS Uterine dilatation that does not make FBS possible. HIV Hepatitis Fetuses at increased risk of hemorrhage.
Where it's running
-
Fundación Jimenez Diaz Y Hospital La Zarzuela
Madrid, Spain Recruiting -
Hospital Universitario Sanitas La Zarzuela
Madrid, Spain Recruiting
Study contacts
- Study coordinator: Raquel Maqueda, Matrona
- Email: raquel.maquedamoreno@usp.ceu.es
- Phone: +34 915504800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dual-system transvaginal fetal pulse oximetry
This tests a transvaginal fetal pulse oximetry sensor to collect fetal oxygen saturation and pulse waveforms from women in labor to help develop signal-processing algorithms.
-
Virtual reality versus in-person progressive muscle relaxation for pregnant people with preeclampsia
This trial will test whether virtual reality–guided progressive muscle relaxation or face-to-face progressive muscle relaxation better reduces stress and improves maternal and fetal outcomes in hospitalized pregnant people with preeclampsia at or after 26 weeks.
-
Keeping the umbilical cord intact during resuscitation after emergency cesarean delivery
This will test whether keeping the umbilical cord attached for 3–5 minutes during resuscitation helps term babies born by emergency C-section who aren't breathing.
-
Oxygen supplementation for mothers during labor to help babies in distress
This study is testing if giving extra oxygen to mothers during labor can help their babies who are in distress feel better and avoid complications.
-
Capturing fetal heart activity using ECG technology
This study is testing if a special heart monitor can accurately capture a baby's heartbeat in pregnant women who are 32 weeks along or more.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.